Parametric G-computation for indirect treatment comparison
This method compares treatments across different clinical trials when individual patient data is limited. It adjusts for differences in patient characteristics by using a statistical model to predict outcomes and then averages these predictions to estimate the overall treatment effect in a target population. It works better than existing methods when patient groups in trials are very different.
At a glance
Use when
Comparing treatments across trials with limited individual patient data, especially when effect modifiers differ between populations and covariate overlap is poor; when marginal (not conditional) treatment effects are required for decision-making.
Avoid when
When no individual patient data is available at all, when key effect modifiers are unmeasured, or when the outcome model cannot be reliably specified.
Inputs
Individual patient data from one trial, aggregate data from another trial, covariates that are effect modifiers, a fitted outcome regression model (e.g., GLM or Cox model), and the target population's covariate distribution.
Outputs
Marginal treatment effect estimate (e.g., risk difference, log odds ratio, hazard ratio) adjusted for covariate imbalances, with associated uncertainty intervals; optionally, posterior distributions in a Bayesian framework.
How it works
Parametric G-computation is a population adjustment method for indirect treatment comparisons that marginalizes over covariate distributions using outcome regression within generalized linear or Cox models. It separates the estimation of the outcome model from the marginal effect calculation, enabling valid inference on population-averaged treatment effects. The method supports Bayesian implementation, improves precision and accuracy over matching-adjusted indirect comparison (MAIC), and corrects bias from non-collapsible effect measures by targeting marginal rather than conditional effects.
- HTA domains
- Clinical Effectiveness, Costs & Economic Evaluation, Patient and Social Aspects
- Assumptions
- Correct specification of the outcome regression model, no unmeasured effect modification, common support or transportability across populations, and consistency of treatment effects within covariate levels.
- Strengths
- Produces unbiased marginal treatment effect estimates under correct model assumptions,More precise and accurate than MAIC, especially with poor covariate overlap,Allows extrapolation beyond observed covariate space via regression modeling,Separates nuisance model estimation from marginal effect inference,Compatible with Bayesian frameworks for probabilistic synthesis
- Limitations
- Relies on correct specification of the outcome regression model,Sensitive to model misspecification, particularly in non-linear models,Assumes all effect modifiers are measured and included,Computational complexity increases with number of covariates
- Also known as
- Parametric G-computation, G-computation for marginal treatment effects, Regression-adjusted marginalization method
Questions this answers
- › How can we compare treatments from different clinical trials when patient-level data is limited?
- › How can we adjust for imbalances in effect modifiers across trials?
- › How can we estimate marginal treatment effects when using regression models with non-collapsible outcomes?
- › What methods are more robust than MAIC when covariate overlap is poor?
- › How can Bayesian frameworks be integrated into indirect treatment comparisons?
- › How can outcome regression be used to produce compatible indirect comparisons?
References & sources
Similar by meaning
Beta record. Generated from the primary source via AI extraction and independent audit, pending final human review.